» Articles » PMID: 28493079

TLR2 Regulates Allergic Airway Inflammation and Autophagy Through PI3K/Akt Signaling Pathway

Overview
Journal Inflammation
Date 2017 May 12
PMID 28493079
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptors (TLRs) are innate pattern recognition receptors that play a critical role in allergic inflammation, yet their contribution to autophagy in asthma remains poorly defined. Here, we investigate the role of Toll-like receptor 2 (TLR2) in phosphoinositide 3-kinases/protein kinase B (PI3K/Akt) pathway-mediated autophagy in ovalbumin-induced airway inflammation in mice. Wild-type (WT) and TLR2-knockout (TLR2) C57BL/6 mice were ovalbumin-sensitized and ovalbumin-challenged. In ovalbumin-challenged WT mice, enhanced expression of TLR2 in lung tissue, remarkable inflammatory cell infiltrates, goblet cell hyperplasia, and increased mucus production were observed. The number of inflammatory cells and interleukin-13 (IL-13) levels increased, while interferon-gamma (IFN-γ) levels decreased in bronchoalveolar lavage fluid. Expression of PI3K, phospho-Akt, Beclin-1 and LC3-II was enhanced significantly. These changes were mitigated dose-dependently in 3-methyl adenine-treated mice. In contrast, similar but weaker changes were found in ovalbumin-challenged TLR2 mice, and the changes were not significantly attenuated by 3-methyl adenine treatment. These results indicate that TLR2 confers a pivotal role in allergic airway inflammation via regulating the PI3K/Akt signaling pathway-related autophagy in mice.

Citing Articles

Bioinformatics and Network Pharmacology Identify the Therapeutic Role of Guominkang in Allergic Asthma by Inhibiting PI3K/Akt Signaling.

Zhang H, Zhang H, Wang L, Zhang Y, Hu L, Liu J J Inflamm Res. 2025; 18:2805-2821.

PMID: 40026302 PMC: 11871930. DOI: 10.2147/JIR.S484251.


The interplay between probiotics and host autophagy: mechanisms of action and emerging insights.

Sadeghloo Z, Nabavi-Rad A, Zali M, Klionsky D, Yadegar A Autophagy. 2024; 21(2):260-282.

PMID: 39291740 PMC: 11759520. DOI: 10.1080/15548627.2024.2403277.


inhibits the TNF-α-induced increase in intestinal epithelial tight junction permeability via a TLR-2 and PI3K-dependent inhibition of NF-κB activation.

Haque M, Kaminsky L, Abdulqadir R, Engers J, Kovtunov E, Rawat M Front Immunol. 2024; 15:1348010.

PMID: 39081324 PMC: 11286488. DOI: 10.3389/fimmu.2024.1348010.


Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling.

Ren L, Qiao G, Zhang S, Zhang Z, Lv S Cell Biochem Biophys. 2024; 82(3):2673-2685.

PMID: 38954352 DOI: 10.1007/s12013-024-01377-8.


Preparation and in vivo evaluation of nano sized cubosomal dispersion loaded with Ruta graveolens extracts as a novel approach to reduce asthma-mediated lung inflammation.

Alyami M, Hamdan D, Khalil H, Orabi M, Aborehab N, Osama N Saudi Pharm J. 2024; 32(3):101968.

PMID: 38352238 PMC: 10862413. DOI: 10.1016/j.jsps.2024.101968.


References
1.
Goulopoulou S, McCarthy C, Webb R . Toll-like Receptors in the Vascular System: Sensing the Dangers Within. Pharmacol Rev. 2016; 68(1):142-67. PMC: 4709508. DOI: 10.1124/pr.114.010090. View

2.
Nashed B, Zhang T, Al-Alwan M, Srinivasan G, Halayko A, Okkenhaug K . Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol. 2007; 37(2):416-24. DOI: 10.1002/eji.200636401. View

3.
Condliffe A, Cadwallader K, Walker T, Rintoul R, Cowburn A, Chilvers E . Phosphoinositide 3-kinase: a critical signalling event in pulmonary cells. Respir Res. 2001; 1(1):24-9. PMC: 59538. DOI: 10.1186/rr8. View

4.
Larsen J, Musavian H, Butt T, Ingvorsen C, Thysen A, Brix S . Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology. 2014; 144(2):333-42. PMC: 4298427. DOI: 10.1111/imm.12376. View

5.
Holtzman M . Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 2012; 122(8):2741-8. PMC: 3408734. DOI: 10.1172/JCI60325. View